Compare Neurocrine Biosciences Inc (NBIX) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Veritone Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Neurocrine Biosciences Inc is far larger — about 178.3× Veritone Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | VERI | |
|---|---|---|
Market Cap | $17.40B | $97.60M |
Sector | Health | Technology |
52-Week High | $180.55 | $8.39 |
52-Week Low | $123.10 | $1.02 |
Enterprise Value | $16.49B | $129.63M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
